<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        13-349-10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DICLAC 75MG ID TABLETS
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DICLOFENAC SODIUM
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        75
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Prolonged-release tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        24.85
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="HEXAL" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            HEXAL
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 360]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Farouk, Maamoun Tamer & CO
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            HEXAL
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        M01AB05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Diclofenac sodium, the active substance in Diclac belongs to a group of medicines called non- steroidal anti-inflammatory drugs (NSAIDs), which are used to treat pain and inflammation. Diclofenac relieves symptoms of inflammation, such as swelling and pain, and also reduces fever. It has no effect on the causes of inflammation or fever.</p><p>&nbsp;</p><p>Diclac can be used to treat the following conditions:</p><p>&nbsp; &nbsp; &nbsp;rheumatism, including inflammatory joint pain (arthritis), joint degeneration (arthrosis) and certain types of back pain (vertebral joint disease).</p><p>&nbsp; &nbsp; &nbsp;painful, inflamed so called frozen shoulder.</p><p>&nbsp;</p><p>The active substance in these tablets (diclofenac sodium) is released into the body over a prolonged period of time. The tablets are known as &lsquo;modified release&rsquo; tablets. For this reason, they are not recommended if you need rapid or immediate symptom relief.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do NOT take Diclac if you:</strong></p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1026" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:.45pt;width:17.05pt;height:25.1pt;z-index:251659264;
 mso-position-horizontal-relative:page' coordorigin="1419,9" coordsize="341,502">
 <v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75"
  o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="_x0000_s1027" type="#_x0000_t75" style='position:absolute;
  left:1419;top:9;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1028" type="#_x0000_t75" style='position:absolute;
  left:1419;top:265;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="33" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image002.gif" />are allergic to diclofenac or any of the other ingredients of this medicine (listed in section 6) have a stomach ulcer or an ulcer elsewhere in your gut</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:shape id="_x0000_i1034" type="#_x0000_t75"
 style='width:17pt;height:12pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />&nbsp;&nbsp;&nbsp; &nbsp;have any bleeding from your stomach or gut, signs of which may include blood in the stools or black, tarry stools</p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1029" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:.45pt;width:17.05pt;height:63.5pt;z-index:251660288;
 mso-position-horizontal-relative:page' coordorigin="1419,9" coordsize="341,1270">
 <v:shape id="_x0000_s1030" type="#_x0000_t75" style='position:absolute;left:1419;
  top:9;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1031" type="#_x0000_t75" style='position:absolute;
  left:1419;top:268;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1032" type="#_x0000_t75" style='position:absolute;
  left:1419;top:522;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1033" type="#_x0000_t75" style='position:absolute;
  left:1419;top:779;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1034" type="#_x0000_t75" style='position:absolute;
  left:1419;top:1033;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="85" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image004.gif" />have ever had bleeding or perforation in the stomach or gut, related to previous NSAID therapy have a history of ulcers or bleeding in the stomach or gut (occurring at least twice)</p><p>have severe liver or kidney failure (severe liver or kidney disease) are in the last three months (third trimester) of pregnancy</p><p>have ever had an attack of asthma or wheezing, or chest pain, or a widespread itchy skin rash (urticaria), or a hay fever-like runny nose after taking other NSAIDs such as acetylsalicylic acid or ibuprofen</p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1035" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:.45pt;width:17.05pt;height:37.8pt;z-index:251661312;
 mso-position-horizontal-relative:page' coordorigin="1419,9" coordsize="341,756">
 <v:shape id="_x0000_s1036" type="#_x0000_t75" style='position:absolute;left:1419;
  top:9;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1037" type="#_x0000_t75" style='position:absolute;
  left:1419;top:265;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1038" type="#_x0000_t75" style='position:absolute;
  left:1419;top:520;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="50" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image005.gif" />are currently suffering from a bleeding or a bleeding disorder suffer from an abnormal condition of the blood (blood dyscrasia)</p><p>suffer from problems with your blood count (Bone marrow depression): lower white blood cells (sometimes severe with an increased risk for infection); lower platelet count (with an increased risk of bleeding and bruising) or lower red blood cell count (dizziness, headache). This might be happening after a radiation therapy.</p><p><!--[if gte vml 1]><v:shape id="_x0000_i1033" type="#_x0000_t75"
 style='width:17pt;height:12pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />&nbsp;&nbsp;&nbsp; &nbsp;have established heart disease and/or cerebrovascular disease e.g. if you have had a heart attack, stroke, mini-stroke (TIA) or blockages to blood vessels to the heart or brain or an operation to clear or bypass blockages</p><p><!--[if gte vml 1]><v:shape id="image1.png" o:spid="_x0000_s1072"
 type="#_x0000_t75" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:.4pt;width:17.05pt;height:12.25pt;z-index:251643904;
 visibility:visible;mso-wrap-style:square;mso-wrap-distance-left:0;
 mso-wrap-distance-top:0;mso-wrap-distance-right:0;mso-wrap-distance-bottom:0;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:page;
 mso-position-vertical:absolute;mso-position-vertical-relative:text'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />have or have had problems with your blood circulation (peripheral arterial disease)</p><p>&nbsp;</p><p>If any of these apply to you or you are not sure about anything, ask your doctor or pharmacist.</p><p>&nbsp;</p><p>Warnings and precautions</p><p>Talk to your doctor or pharmacist before taking Diclac if you:</p><p><!--[if gte vml 1]><v:shape id="_x0000_i1032" type="#_x0000_t75"
 style='width:17pt;height:12pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />&nbsp;&nbsp;&nbsp; &nbsp;have ever had any stomach/gut problems such as an ulcer, bleeding or black stools, or have suffered stomach discomfort or heartburn after taking NSAIDs in the past</p><p><!--[if gte vml 1]><v:shape id="_x0000_i1031" type="#_x0000_t75"
 style='width:17pt;height:12pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />&nbsp;&nbsp;&nbsp; &nbsp;suffer from asthma, hay fever, or any other long-standing problem of the respiratory system such as nasal polyps or chronic obstructive airways disease</p><p><!--[if gte vml 1]><v:shape id="_x0000_i1030" type="#_x0000_t75"
 style='width:17pt;height:12pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />&nbsp;&nbsp;&nbsp; &nbsp;have a tendency to develop allergic skin rashes, skin itching or hives</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; have an inflammatory bowel disease, such as ulcerative colitis or Crohn&rsquo;s disease</p><p><!--[if gte vml 1]><v:shape id="_x0000_i1029" type="#_x0000_t75"
 style='width:17pt;height:12pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />&nbsp;&nbsp;&nbsp; &nbsp;have a bleeding disorder or any other blood problems including the rare liver condition called porphyria</p><p><!--[if gte vml 1]><v:shape id="_x0000_i1028" type="#_x0000_t75"
 style='width:17pt;height:12pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />&nbsp;&nbsp;&nbsp; &nbsp;have an inflammatory disease called systemic lupus erythematosus, or any connective tissue disease</p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1039" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:.45pt;width:17.05pt;height:63.75pt;z-index:251662336;
 mso-position-horizontal-relative:page' coordorigin="1419,9" coordsize="341,1275">
 <v:shape id="_x0000_s1040" type="#_x0000_t75" style='position:absolute;left:1419;
  top:9;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1041" type="#_x0000_t75" style='position:absolute;
  left:1419;top:268;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1042" type="#_x0000_t75" style='position:absolute;
  left:1419;top:525;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1043" type="#_x0000_t75" style='position:absolute;
  left:1419;top:782;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1044" type="#_x0000_t75" style='position:absolute;
  left:1419;top:1039;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="85" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image006.gif" />have heart problems smoke</p><p>have diabetes</p><p>have angina, blood clots, high blood pressure, raised cholesterol or raised triglycerides have any liver or kidney problems</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <!--[if gte vml 1]><v:shape
 id="image2.png" o:spid="_x0000_s1071" type="#_x0000_t75" style='position:absolute;
 left:0;text-align:left;margin-left:347.7pt;margin-top:1.2pt;width:17.3pt;
 height:12.25pt;z-index:-251663360;visibility:visible;mso-wrap-style:square;
 mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:0;
 mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:page;mso-position-vertical:absolute;
 mso-position-vertical-relative:text'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image007.png"
  o:title=""/>
 <w:wrap anchorx="page"/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image008.gif" />think you are dehydrated, perhaps due to diarrhoea, low uid intake or sickness, or in association with surgery</p><p><!--[if gte vml 1]><v:shape
 id="image1.png" o:spid="_x0000_i1027" type="#_x0000_t75" style='width:17pt;
 height:12pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
  o:title=""/>
</v:shape><![endif]--><img width="23" height="16" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image003.gif" />&nbsp;&nbsp;&nbsp; &nbsp;have a viral infectious disease caused by varicella zoster</p><p>&nbsp;</p><p>If any of these apply to you, your doctor may want to give you special advice or change your treatment.</p><p>&nbsp;</p><p>Side effects may be minimised by using the lowest effective dose for the shortest duration necessary.</p><p>&nbsp;</p><p>Elderly people may be more sensitive to the effects of Diclac than younger adults. If you are an elderly person (65 and over), it is important to follow your doctor&rsquo;s instructions very carefully and take the lowest number of tablets that gives adequate symptom relief. It is especially important for elderly people to report any undesirable effects promptly to the doctor or pharmacist (see section 4 &ldquo;Possible side effects&rdquo;).</p><p>&nbsp;</p><p>The doctor may also prescribe another medicine (such as misoprostol or proton pump inhibitors) to protect the stomach to be taken at the same time, particularly if you have had stomach problems before, if you are elderly or are taking low-dose acetylsalicylic acid (ASA) or certain other medicines likely to increase gastrointestinal risk.</p><p>&nbsp;</p><p>Tell your doctor if you recently had or you are going to have a surgery of the stomach or intestinal tract before taking Diclac, as Diclac can sometimes worsen wound healing in your gut after surgery.</p><p>&nbsp;</p><p>Diclac may reduce or mask symptoms of an infection such as headache or high temperature. This could make the infection more difficult to detect and treat. If you feel unwell and see a doctor, remember to mention that you are taking Diclac.</p><p>&nbsp;</p><p>Children and adolescents</p><p>Diclac is not recommended for use in children and adolescents under the age of 18 years.</p><p>&nbsp;</p><p>Other medicines and Diclac</p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This is important because some medicines should not be taken together with Diclac.</p><p>&nbsp;</p><p>The following medicines, when taken together with Diclac, could increase the risk of bleeding or ulceration in your stomach or gut, so you should tell your doctor or pharmacist if you are taking any of these other medicines:</p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1045" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:.45pt;width:17.05pt;height:50.9pt;z-index:251663360;
 mso-position-horizontal-relative:page' coordorigin="1419,9" coordsize="341,1018">
 <v:shape id="_x0000_s1046" type="#_x0000_t75" style='position:absolute;left:1419;
  top:9;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1047" type="#_x0000_t75" style='position:absolute;
  left:1419;top:268;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1048" type="#_x0000_t75" style='position:absolute;
  left:1419;top:525;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1049" type="#_x0000_t75" style='position:absolute;
  left:1419;top:781;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="67" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image009.gif" />oral corticosteroids, used to treat inflamed areas of the body anticoagulants such as warfarin or phenprocoumon, used to thin the blood</p><p>selective serotonin-reuptake inhibitors (SSRIs), used to treat some types of depression</p><p>other NSAIDs including COX-2 (cyclo-oxgenase-2) inhibitors, such as acetylsalicylic acid and ibuprofen, used to relieve inflammation/pain</p><p>&nbsp;</p><p>Tell your doctor or pharmacist if you are taking any of the following:</p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1050" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:.6pt;width:17.05pt;height:63.65pt;z-index:251664384;
 mso-position-horizontal-relative:page' coordorigin="1419,12" coordsize="341,1273">
 <v:shape id="_x0000_s1051" type="#_x0000_t75" style='position:absolute;left:1419;
  top:12;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1052" type="#_x0000_t75" style='position:absolute;
  left:1419;top:268;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1053" type="#_x0000_t75" style='position:absolute;
  left:1419;top:526;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1054" type="#_x0000_t75" style='position:absolute;
  left:1419;top:783;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1055" type="#_x0000_t75" style='position:absolute;
  left:1419;top:1039;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="84" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image010.gif" />lithium, used to treat some disorders of mood, such as mania or depression digoxin, used for heart problems</p><p>amiodarone, used for irregular heart beat diuretics, used to increase the amount of urine</p><p>antihypertensives, such as ACE inhibitors, angiotensin II receptor antagonists or beta-blockers, used to treat high blood pressure (or certain other heart problems)</p><p><!--[if gte vml 1]><v:group id="_x0000_s1056" style='position:absolute;
 left:0;text-align:left;margin-left:70.95pt;margin-top:.4pt;width:17.05pt;
 height:50.9pt;z-index:251665408;mso-position-horizontal-relative:page'
 coordorigin="1419,8" coordsize="341,1018">
 <v:shape id="_x0000_s1057" type="#_x0000_t75" style='position:absolute;left:1419;
  top:8;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1058" type="#_x0000_t75" style='position:absolute;
  left:1419;top:267;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1059" type="#_x0000_t75" style='position:absolute;
  left:1419;top:524;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1060" type="#_x0000_t75" style='position:absolute;
  left:1419;top:780;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="67" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image011.gif" />blood-thinning medicines (anti-coagulants)</p><p>medicines taken by mouth to treat diabetes (oral anti-diabetics) methotrexate, used to treat severe arthritis and some cancers</p><p>ciclosporin or tacrolimus, used to prevent rejection after organ transplants or to treat some inflammatory diseases</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1061" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:3.7pt;width:17.05pt;height:76.35pt;z-index:251666432;
 mso-position-horizontal-relative:page' coordorigin="1419,74" coordsize="341,1527">
 <v:shape id="_x0000_s1062" type="#_x0000_t75" style='position:absolute;left:1419;
  top:74;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1063" type="#_x0000_t75" style='position:absolute;
  left:1419;top:331;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1064" type="#_x0000_t75" style='position:absolute;
  left:1419;top:588;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1065" type="#_x0000_t75" style='position:absolute;
  left:1419;top:842;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1066" type="#_x0000_t75" style='position:absolute;
  left:1419;top:1099;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1067" type="#_x0000_t75" style='position:absolute;
  left:1419;top:1356;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="101" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image012.gif" />quinolone antibiotics, used to treat certain infections trimethoprim, used to treat bacterial infections</p><p>colestipole and colestyramine, usd to treat a high cholesterol level in the blood sulfinpyrazone, used to treat gout</p><p>fluconazole and voriconazole, used to treat fungal infections phenytoin, used to treat seizures</p><p>&nbsp;</p><p>Pregnancy, breast-feeding and fertility</p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p>&nbsp;</p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1068" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:6pt;width:15.6pt;height:24pt;z-index:251667456;
 mso-position-horizontal-relative:page' coordorigin="1419,120" coordsize="312,480">
 <v:shape id="_x0000_s1069" type="#_x0000_t75" style='position:absolute;left:1419;
  top:120;width:312;height:221'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image013.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1070" type="#_x0000_t75" style='position:absolute;
  left:1419;top:379;width:312;height:221'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image013.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="21" height="32" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image014.gif" />Do not take Diclac during the first six months of pregnancy unless your doctor advises it.</p><p>Do not take this medicine during the last three months of pregnancy as it could harm the unborn child or cause problems during delivery.</p><p><!--[if gte vml 1]><v:shape id="_x0000_i1026" type="#_x0000_t75"
 style='width:15.5pt;height:11pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image013.png"
  o:title=""/>
</v:shape><![endif]--><img width="21" height="15" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image015.gif" />&nbsp;&nbsp;&nbsp; &nbsp;This medicine, like other NSAIDs, may make it more difficult to become pregnant, so it is best not to take this medicine if you are planning a pregnancy or have had previous difficulties becoming pregnant.</p><p><!--[if gte vml 1]><v:shape
 id="image3.png" o:spid="_x0000_i1025" type="#_x0000_t75" style='width:15.5pt;
 height:11pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image013.png"
  o:title=""/>
</v:shape><![endif]--><img width="21" height="15" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image015.gif" />&nbsp;&nbsp;&nbsp; &nbsp;Do not use Diclac while you are breast-feeding. It might be harmful for your infant.</p><p>&nbsp;</p><p>Driving and using machines</p><p>Diclofenac has not been shown to impair your ability to drive or operate machinery.</p><p>&nbsp;</p><p>However, if you develop side effects such as vision problems, dizziness or drowsiness (see section 4), do not drive or use machines.</p><p>&nbsp;</p><p>Diclac contains sucrose and sodium</p><p>If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.</p><p>This medicine contains less than 1 mmol (23 mg) sodium, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.</p><p>&nbsp;</p><p>Your doctor will tell you how many tablets to take and how long to take them for. It is important to take the lowest dose which adequately controls your inflammation/pain, and for the shortest possible period of time. Depending on how you first respond to the treatment, your doctor might suggest changing to a higher or lower dose. Never exceed your doctor&rsquo;s recommended dose.</p><p>&nbsp;</p><p>The recommended dose is: Adults (over 18 years)</p><p><!--[if gte vml 1]><v:group
 id="_x0000_s1026" style='position:absolute;left:0;text-align:left;
 margin-left:70.95pt;margin-top:.75pt;width:17.05pt;height:38.05pt;z-index:251668480;
 mso-position-horizontal-relative:page' coordorigin="1419,15" coordsize="341,761">
 <v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75"
  o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="_x0000_s1027" type="#_x0000_t75" style='position:absolute;
  left:1419;top:15;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1028" type="#_x0000_t75" style='position:absolute;
  left:1419;top:271;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><v:shape id="_x0000_s1029" type="#_x0000_t75" style='position:absolute;
  left:1419;top:531;width:341;height:245'>
  <v:imagedata src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.png"
   o:title=""/>
 </v:shape><w:wrap anchorx="page"/>
</v:group><![endif]--><img width="23" height="51" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image002.gif" />The starting dose is usually 75-150 mg diclofenac sodium per day. The maximum dose is 150 mg per day.</p><p>For milder symptoms or long-term therapy, 75 mg or 100 mg per day is usuallysufficient.</p><p>&nbsp;</p><p>Elderly (over 65 years)</p><p>&nbsp;</p><p>Elderly people tend to be more at risk of the side effects of NSAIDs such as diclofenac, so it is particularly important that elderly people take the lowest possible dose of diclofenac that is effective.</p><p>&nbsp;</p><p>Method of administration</p><p>Swallow the tablets whole, with liquid, preferably during a meal. Do not crush or chew the tablets.</p><p>&nbsp;</p><p>If you take more Diclac than you should</p><p>If you have accidentally taken&nbsp; too&nbsp; many&nbsp; Diclac&nbsp; tablets,&nbsp; tell&nbsp; your&nbsp; doctor&nbsp; or&nbsp; pharmacist&nbsp; or&nbsp; go straight to the nearest hospital Accident and Emergency unit. You may require medical attention. Symptoms of an overdose might include vomiting, diarrhoea, dizziness, a ringing in the ear (tinnitus), convulsions or severe stomach pain, bloody or black stools.</p><p>&nbsp;</p><p>If you forget to take Diclac</p><p>If you forget to take a dose, take one as soon as you remember. If it is nearly time for your next dose when you remember, simply take the next dose at the usual time. Do not take a double dose to make up for the forgotten dose.</p><p>&nbsp;</p><p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>Serious side effects</p><p><strong>If any of the following serious side effects happen, stop taking this medicine and tell your doctor immediately or go to the emergency department at your nearest hospital. </strong>You may need urgent medical attention.</p><ul><li>severe pain in the stomach or gut, bloody or black stools, vomiting blood</li><li>unusual bleeding or bruising which may be signs of reduced number of blood platelets high fever or persistent sore throat (possible signs of agranulocytosis)</li><li>serious allergic reaction which causes difficulty in breathing or dizziness, or swelling of the face, lips, mouth, tongue or throat often associated with rash and itching</li><li>wheezing and feelings of tightness in the chest (signs of asthma) stiff neck (signs of meningitis)</li><li>fits</li><li>high blood pressure</li><li>red or purple skin (possible signs of blood vessel inflammation)</li><li>skin rash with blisters, blistering of the lips, eyes and mouth, skin inflammation with flaking or peeling</li><li>yellowing of the skin or eyes (signs of hepatitis)</li><li>blood in urine, excess of protein in the urine, severe decreased urine output (signs of kidney disorders)</li><li>inflammation of the pancreas which causes severe pain in the abdomen and back</li><li>sudden and severe headache, nausea, dizziness, numbness, inability or difficulty to speak, paralysis (signs of stroke)</li></ul><p>&nbsp;</p><p>The above serious side effects are <strong>rare </strong>(may affect up to 1 in 1,000 people) or <strong>very rare </strong>(may affect up to 1 in 10,000 people)</p><ul><li>&nbsp; &nbsp; &nbsp;Serious heart problems such as chest pain and shortness of breath (signs of myocardial infarction or heart failure) may occur with frequency <strong>uncommon </strong>(may affect up to 1 in 100 people).</li><li>&nbsp; &nbsp; &nbsp;Chest pain, which can be a sign of a potentially serious allergic reaction called Kounis syndrome (frequency <strong>not known</strong>, cannot be estimated from the available data)</li><li>&nbsp; &nbsp; &nbsp;Mild cramping and tenderness of the abdomen, starting shortly after the start of the treatment with Diclac and followed by rectal bleeding or bloody diarrhoea usually within 24 hours of the onset of abdominal pain (frequency <strong>not known</strong>, cannot be estimated from the available data).</li></ul><p>&nbsp;</p><p>Other side effects</p><p><strong>&nbsp;</strong></p><p><strong>Common side effects </strong>(may affect up to 1 in 10 people):</p><ul><li>headache, dizziness</li><li>nausea, vomiting, diarrhoea, indigestion, abdominal pain, flatulence (wind), loss of appetite</li><li>change in liver function (e.g. level of transaminases seen in blood tests)</li><li>skin rash</li><li>vertigo</li></ul><p>&nbsp;</p><p><strong>Uncommon side effects </strong>(may affect up to 1 in 100 people):</p><ul><li>&nbsp;feeling your heartbeat</li></ul><p>&nbsp;</p><p><strong>Rare side effects </strong>(may affect up to 1 in 1,000 people): sleepiness</p><p>stomach pain itchy rash</p><p>swelling of arms, hands, legs and feet (oedema)</p><p>&nbsp;</p><p><strong>Very rare side effects </strong>(may affect up to 1 in 10,000 people):</p><ul><li>decrease in red or white blood cells, with symptoms like paleness, fatigue, dark urine, pale stool, higher risk for infections</li><li>disorientation, depression, anxiety, difficulty sleeping, nightmares, irritability, loss of contact with reality (psychotic disorder)</li><li>tingling or numbness in the hands or feet</li><li>memory impairment</li><li>trembling</li><li>problems with taste, vision, hearing (such as ringing in the ears)</li><li>inflammation of the lungs which causes breathlessness and chest pain (pneumonitis)</li><li>constipation or other bowel problems including colitis (symptoms include persistent diarrhoea) or worsening of existing inflammatory bowel disorders</li><li>sore mouth, sore tongue, sore gullet</li><li>ulcer of the oesophagus (the tube that carries food from the throat to the stomach)</li><li>nettle rash, itching, unusual skin sensitivity to sunlight, resulting in red, swollen, blistered skin hair loss</li><li>severe liver problems</li></ul><p>&nbsp;</p><p>Medicines such as Diclac may be associated with a small increased risk of heart attack (&quot;myocardial infarction&quot;) or stroke.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Store below 25&deg;C. Store in a dry place</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The active substance is diclofenac sodium.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; One prolonged-release tablet (two-layer tablet) contains 75 mg diclofenac sodium:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12.5 mg diclofenac sodium, immediate release and 62.5 mg diclofenac sodium, slow release. The abbreviation ID stands for Initial and Depot effect.</p><p>Diclac 75 mg:</p><p>calcium hydrogen phosphate dihydrate, carboxymethyl starch sodium (type A) (Ph.Eur.), microcrystalline cellulose, hypromellose, lactose monohydrate, magnesium stearate (Ph.Eur.),</p><p>maize starch, colloidal silicon dioxide, ferric(|ll) oxide (E 172).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Diclac 75 mg:
Diclac® 75 mg ID are round bilayer tablets (white, pink) with plain surface. Cartons containing 10, 20, 30, 50, 60, 90, 100 or 100 x 1 prolonged-release tablets in PVC/ PVDC/aluminium or PVC/PE/PVDC/aluminium blisters
Not all pack sizes may be marketed.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong></p><p>HEXAL AG</p><p>Industriestrasse 25, 83607 Holzkirchen, Germany</p><p><strong>Manufacturer</strong></p><p>HEXAL</p><p>Otto-von-Guericke-Allee 1, 39179 Barleben, Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                07/2020.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي ديكلوفيناك الصوديوم ألا وهو المادة الفعَّالة في عقار ديكلاك إلى مجموعة من الأدوية تُسمى مضادات الالتهاب غير الستيرويدية تُستخدم لعلاج الألم والالتهاب. يخفف ديكلوفيناك أعراض الالتهاب، مثل التَّورم والألم، ويُخفض الحمى أيضًا. ليس له تأثير على مُسببات الالتهاب أو الحُمى.</p><p dir="RTL">يمكن استخدام عقار ديكلاك لعلاج الحالات التَّالية:</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; الروماتيزم، بما في ذلك الآلام الالتهابية بالمفاصل (التهاب المفاصل)، تَنَكُس المفاصل (الفُصال) وأنواع مُعينة من آلام الظهر (مرض المَفْصِلِ الفِقْرِيّ)،</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; ألم والتهاب بالكتف ما يُسمى بالكتف المتجمدة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يتم إفراز المادة الفعَّالة الموجودة بهذه الأقراص (ديكلوفيناك الصوديوم) بالجسم على مدار فترة زمنية طويلة. تُعرف الأقراص باسم الأقراص &quot;مُعدَّلة الإفراز&quot;. لهذا السبب، لا يُوصى بتناوُلها إذا كنت بحاجة إلى شفاء سريع أو فوري للأعراض.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحظر تناوُل عقار ديكلاك في الحالات التالية:</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه ديكلوفيناك أو تجاه أيِّ مكون من المكونات الأخرى بهذا الدَّواء (المدرجة في قسم: 6)</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تُعاني من قرحة بالمعدة أو قرحة بمكان آخر بالأمعاء.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تُعاني من أي نزيف بالمعدة أو الأمعاء قد تشمل علاماته وجود دم بالبراز أو براز أسود قطراني.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد عانيت سابقًا من نزيف أو انثقاب بالمعدة أو الأمعاء ذي صلة بعلاج سابق بمضادات الالتهاب غير الستيرويدية.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك تاريخ من الإصابة بقُرح أو نزيف بالمعدة أو الأمعاء (يتم التعرض لهما مرتين على الأقل).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من فشل شديد بالكبد أو الكُلى (مرض كبدي أو كُلوي شديد).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ خلال الثلاثة أشهر الأخيرة (الثُلث الثالث) من الحَمْل.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا عانيت سابقًا من نوبة ربو أو أزيز بالصدر أو ألم بالصدر أو طفح جلدي مثير للحكة واسع الانتشار (أرتكاريا) أو سيلان أنف مشابه لحُمَّى القش بعد تناوُل مضادات التهاب غير ستيرويدية أخرى مثل حمض أسيتيل الساليسيليك أو الإيبوبروفين.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني حاليًّا من نزيف أو اضطراب نزفي.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اضطراب بالدَّم (اعْتِلاَل الدَّم).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل بتعداد خلايا الدَّم (كبت النخاع العظمي): انخفاض خلايا الدَّم البيضاء (أحيانًا يكون شديدًا ومصحوبًا بازدياد خطر الإصابة بعدوى)؛ انخفاض تعداد الصفائح الدموية (مصحوب بازدياد خطر الإصابة بنزيف وكدمات) أو انخفاض تعداد خلايا الدَّم الحمراء (دوخة، صداع). قد تحدث تلك المشاكل بعد الخضوع للعلاج الإشعاعي.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصاب بمرض قلبي قائم و/ أو مرض بالأوعية الدَّموية بالمخ على سبيل المثال: إذا عانيت سابقًا من نوبة قلبية، سكتة دماغية، سكتة دماغية صغرى (نوبة إقفارية عابرة) أو انسداد بالأوعية الدَّموية المؤدية إلى القلب أو المخ أو خضعت لعملية لإزالة أو مجاوزة الانسدادات.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;إذا كنت تعاني أو قد عانيت من قبل من مشاكل بالدَّورة الدَّموية لديك (أمراض الشرايين الطرفية).</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا انطبق عليك أيٌّ مما سبق أو إذا لم تكن متأكدًا من شيء ما، فاسأل طبيبك أو الصيدلي الخاص بك.</p><p dir="RTL">تحذيرات واحتياطات</p><p dir="RTL">تحدَّث إلى طبيبك أو الصيدلي الخاص بك قبل تناول عقار ديكلاك في الحالات التالية:</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت قد عانيت سابقًا من أيِّ مشاكل بالمعدة/الأمعاء مثل قرحة، نزيف أو براز أسود أو كنت عانيت من شعور غير مريح بالمعدة أو حموضة (حُرْقَةُ الفُؤاد) بعد تناوُل مضادات الالتهاب غير الستيرويدية في الماضي.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ربو، حُمَّى القش أو أيِّ مشكلة أخرى قائمة لفترة طويلة بالجهاز التنفسي مثل السَلاَئِل الأَنْفِيَّة أو مرض انسداد المسالك الهوائية المزمن.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كان لديك قابلية للإصابة بطفح جلدي تحسسي، حكة جلدية أو شرى (أرتكاريا).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض الأمعاء الالتهابي، مثل التهاب القولون التقرحي أو مرض كرون.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من اضطراب نزفي أو أيِّ مشاكل أخرى بالدم بما في ذلك حالة كبدية نادرة تُدعى البُرْفيرِيَّة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض التهابي يُدعى الذئبة الحمامية الجهازية أو أيٍّ من أمراض الأنسجة الضامة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل بالقلب.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مدخنًا.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنتِ مصابة بمرض السكري.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من ذبحة صدرية، جلطات دموية، ارتفاع ضغط الدَّم، ارتفاع مستوى الكوليسترول أو الدهون الثلاثية.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أيِّ مشاكل بالكبد أو الكُلى.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تظن أنك تُعاني من جفاف، ربما يكون ناجمًا عن إِسْهال، أو تلقي كميات قليلة من السوائل أو إعياء أو ربما يكون ذا صلة بجراحة قد خضعت لها.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مرض فيروسي مُعدٍ ناجم عن النطاقي الحماقي.</p><p dir="RTL">قد يود طبيبك إعطاؤك نصيحة خاصة أو تغيير علاجك إذا انطبقت عليك أيٌّ من هذه الحالات.</p><p dir="RTL">يُمكِن تقليل الآثار الجانبيَّة باستخدام أقل جرعة فعَّالة لأقصر مدة ضرورية</p><p dir="RTL">قد يكون كبار السن أكثر حساسية تجاه تأثيرات عقار ديكلاك مقارنة بالبالغين الأصغر سنًا. إذا كنت كبير السن (65 عامًا فما أكثر)، فمن الهام أن تتبع تعليمات طبيبك بدقة شديدة وأن تتناول أقل عدد من الأقراص يُخفف أعراضك بما يكفي. من الهام على وجه الخصوص أن يُبلِّغ كبار السن الطبيب أو الصيدلي فورًا بأيِّ آثار جانبية (انظر قسم 4 &quot;الآثار الجانبية المُحتمَلة&quot;).</p><p dir="RTL">&nbsp;قد يصف الطبيب أيضًا دواءًا آخر (مثل ميزوبروستول أو مثبطات مضخة البروتون) يتم تناوُله في الوقت نفسه لحماية المعدة، خاصَّة إذا عانيت سابقًا من مشاكل بالمعدة أو كنت كبير السن أو كنت تتناول جرعة منخفضة من حمض أسيتيل الساليسيليك أو أدوية أخرى مُعينة من المُرجح أن تزيد المخاطر المتعلقة بالجهاز الهضمي.</p><p dir="RTL">أخبِر طبيبك إذا كنت قد خضعت مؤخرًا أو كنت ستخضع لجراحة بالمعدة أو السبيل المعوي قبل تناوُل عقار ديكلاك؛ فقد يتسبب عقار ديكلاك أحيانًا في تدهور التئام الجروح في الأمعاء بعد الخضوع للجراحة.</p><p dir="RTL">قد يحد عقار ديكلاك من أعراض العدوى أو يحجبها مثل الصداع أو ارتفاع درجة الحرارة. قد يُصعِّب ذلك من اكتشاف العدوى وعلاجها. إذا كنت تشعر بالإعياء وستقوم بزيارة الطبيب، احرص على إخباره بأنك تتناول عقار ديكلاك.</p><p dir="RTL">الأطفال والمراهقون</p><p dir="RTL">لا يوصى باستخدام عقار ديكلاك في الأطفال والمراهقين تحت سن 18 عامًا</p><p dir="RTL">تناوُل أدوية أخرى مع عقار ديكلاك</p><p dir="RTL">يُرجى إبلاغ طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أو تناولت مؤخرًا أو قد تتناول أيَّة أدوية أخرى. هذا هام لأنه تُوجد بعض الأدوية التي ينبغي عدم تناوُلها بمصاحبة عقار ديكلاك.</p><p dir="RTL">قد تزيد الأدوية التالية، عند تناوُلها بمصاحبة عقار ديكلاك، من خطر الإصابة بنزيف أو قرح بالمعدة أو الأمعاء، لذلك ينبغي عليك إخبار الطبيب أو الصيدلي الخاص بك إذا كنت تتناول أيًّا من هذه الأدوية الأخرى:</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; الكورتيكوستيرويدات الفموية، التي تُستخدم لعلاج المناطق المُلتهبة من الجسم.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;مضادات التخثر/التجلط، مثل وارفارين أو فينوبروكومون، التي تُستخدم لتسييل الدَّم.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; مثبطات إعادة امتصاص السيروتونين الانتقائية (تُستَخدَم لعلاج بعض أنواع من الاكتئاب)</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;مضادات الالتهاب غير الستيرويدية الأخرى بما في ذلك مثبطات الأكسدة الحلقية-2، مثل حمض أسيتيل الساليسيليك والإيبوبروفين، التي تُستخدم لتخفيف الالتهاب/الألم.</p><p dir="RTL">أخبر طبيبك أو الصيدلي الخاص بك إذا كنت تتناول أيًّا من الأدوية التَّالية:</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; الليثيوم، يُستخدم لعلاج بعض اضطرابات الحالة المزاجية، مثل الهوس أو الاكتئاب.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; ديجوكسين، يُستخدم لعلاج مشاكل القلب.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; أميودارون، يُستخدم لعلاج عدم انتظام ضربات القلب.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; مُدِرات البول، تُستخدم لزيادة كمية البول.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;الأدوية الخافضة لضغط الدَّم، مثل مُثبطات إنزيم تحويل الأنجيوتنسين، مناهضات مستقبلات أنجيوتنسين-2 أو حاصرات بيتا، التي تُستخدم لعلاج ارتفاع ضغط الدَّم (أو بعض المشاكل القلبية الأخرى).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; الأدوية المُسَيَّلة للدم (مضادات التخثر) أدوية يتم تناوُلها عن طريق الفم لعلاج مرض السُّكَّرِي (مضادات مرض السُّكَّرِي الفموية). ميثوتريكسات، يُستخدم لعلاج الْتِهاب المَفاصِلِ الشديد وبعض أنواع السرطان.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;سيكلوسبورين أو تاكروليموس، اللذان يُستخدمان للحيلولة دون رفض الأعضاء بعد زرعها أو لعلاج بعض الأمراض الالتهابية.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; المضادات الحيوية من مجموعة الكينولون، التي تُستخدَم لعلاج بعض العدوى.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;ترايميثوبريم،يُستخدم في علاج العدوى البكتيرية.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; كوليستيبول وكولستيرامين، اللذان يُستَخدَمان لعلاج ارتفاع مستوى الكوليسترول في الدَّم. سَلفينبيرازون، يُستخدم لعلاج مرض النقرس.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; فلوكونازول وفوريكونازول، يُستخدَمان لعلاج العدوى الفطرية.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; فينيتوين, يُستخدَم لعلاج النوبات التشنجية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الحمل والرَّضاعة الطبيعية والخصوبة</p><p dir="RTL">إذا كنتِ حاملًا أو مرضعًا، أو تعتقدين أنكِ قد تكونين حاملًا أو تخططين لذلك، فاستشيري طبيبك أو الصيدلي الخاص بك قبل تناوُل هذا الدَّواء.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; يُحظر تناوُل عقار ديكلاك خلال الستة أشهر الأولى من الحمل ما لم ينصحك طبيبك بذلك.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; يُحظر تناوُل هذا الدواء خلال الأشهر الثلاثة الأخيرة من الحمل فقد يضر الجنين أو يسبب مشاكل أثناء الولادة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; هذا الدواء، مثله مثل مضادات الالتهاب غير الستيرويدية الأخرى،قد يُصعِّب من حدوث الحمل، لذلك يُفضل عدم تناوُل هذا الدواء إذا كنتِ تخططين للحمل أو إذا كنت قد واجهتي صعوبات سابقًا في أن تصبحي حاملًا.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; يُحظر تناوُل عقار ديكلاك إذا كنتِ تمارسين الرضاعة الطبيعية. قد يكون ضارًّا لرضيعك.</p><p dir="RTL">القيادة واستخدام الآلات</p><p dir="RTL">لم يثبت وجود تأثير لديكلوفيناك في القدرة على القيادة أو تشغيل الآلات.</p><p dir="RTL">مع ذلك، فلا تُمارس القيادة أو تستخدم الآلات إذا أُصبت بآثار جانبية مثل مشاكل بالرؤية، دوخة أو نُعاس (انظر قسم 4).</p><p dir="RTL">يحتوي عقار ديكلاك على السكروز والصوديوم.</p><p dir="RTL">إذا كان طبيبك قد أخبرك بأنك لا تتحمل بعض أنواع السكريات، فاتصل به قبل تناول هذا الدَّواء.</p><p>يحتوي هذا الدَّواء على أقل من 1 مللي مول من الصوديوم (23 مجم) من الصوديوم، أي أنه &quot;خالٍ من الصوديوم&quot; بشكل أساسي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">تناول دائمًا هذا الدَّواء بالضبط كما أخبرك طبيبك أو الصيدلي الخاص بك. راجع طبيبك أو الصيدلي الخاص بك إذا لم تكن متأكدًا من كيفية الاستخدام.</p><p dir="RTL">سيخبرك طبيبك بعدد الأقراص التي يجب عليك تناوُلها ومدة تناوُلها. من الهام تناوُل أقل جرعة كافية للتحكم بالالتهاب/الألم الذي تعاني منه ولأقصر مدة ممكنة. قد يقترح طبيبك تغيير الجرعة لجرعة أعلى أو أقل، استنادًا إلى كيفية استجابتك للعلاج أول مرة. يُحظر تجاوز الجرعة التي أوصى بها طبيبك.</p><p dir="RTL">الجرعة المُوصى بها هي:</p><p dir="RTL">في البالغين (أكثر من 18 عامًا).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; عادةً ما تتراوح جرعة البدء بين 75 و150 مجم من ديكلوفيناك الصوديوم في اليوم.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تبلغ الجرعة القصوى 150 مجم في اليوم.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; بالنسبة للأعراض الأبسط أو العلاج طويل الأمد، عادة ما تكون الجرعات 75 مجم أو 100 مجم في اليوم كافية.</p><p dir="RTL">في كبار السن (أكبر من 65 عامًا)</p><p dir="RTL">يميل كبار السن إلى كونهم مُعرضين بشكل أكبر لخطر الإصابة بآثار جانبية ناجمة عن مضادات الالتهاب غير الستيرويدية مثل ديكلوفيناك، لذلك فمن الهام على وجه الخصوص أن يتناول كبار السن أقل جرعة ممكنة فعالة من ديكلوفيناك.</p><p dir="RTL">طريقة التَّناول</p><p dir="RTL">ابتلع الأقراص كاملة، مع السوائل، ويُفضل القيام بذلك أثناء تناوُل إحدى الوجبات.</p><p dir="RTL">لا تسحق الأقراص أو تمضغها.</p><p dir="RTL">إذا تناولت عقار ديكلاك أكثر مما يجب</p><p dir="RTL">إذا كنت قد تناولت كمية كبيرة من أقراص عقار ديكلاك بطريق الخطأ، فأخبر طبيبك أو الصيدلي الخاص بك أو اذهب الى وحدة الحوادث والطوارئ بأقرب مستشفى لك. فقد تحتاج إلى الرعاية الطبية.&nbsp; قد تشمل أعراض الجرعة الزَّائدة قيء، إسهال، دوخة، طنين بالأذن، تشنجات أو ألم شديد بالمعدة، براز مُدمم أو أسود.</p><p dir="RTL">إذا أغفلت تناوُل عقار ديكلاك</p><p dir="RTL">إذا أغفلت تناول إحدى الجرعات، فتناول جرعة بمجرد أن تتذكر. إذا كان موعد جرعتك التَّالية قد اقترب عند تذكرك، ببساطة تناول الجرعة التالية في الموعد المعتاد. لا تتناول جرعة مضاعفة لتعويض جرعة أغفلتها.</p><p>إذا كانت لديك أية أسئلة إضافية حول استخدام هذا الدَّواء، فاستشر طبيبك أو الصيدلي الخاص بك.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">مثله مثل كافة الأدوية، قد يُسبب هذا الدَّواء آثارًا جانبية، على الرَّغم من عدم حدوثها لدى الجميع.</p><p dir="RTL">الآثار الجانبية الخطيرة</p><p dir="RTL">إذا حدث أيٌّ من هذه الآثار الجانبية الخطيرة التالية، فتوقف عن تناول هذا الدواء وأخبر طبيبك فورًا أو اذهب إلى قسم الطوارئ بأقرب مستشفى. قد تحتاج إلى رعاية طبية عاجلة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; ألم شديد بالمعدة أو الأمعاء، براز مُدمم أو أسود، تقيُؤ دم.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; الإصابة بنزيف أو كدمات على نحو غير مُعتاد وقد يكون ذلك علامة تنم عن انخفاض عدد الصفائح الدَّموية.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; حُمّى مرتفعة أو التهاب الحلق المستمر (علامات مُحتملة لندرة خلايا المحببات).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تفاعلات حساسية خطيرة تتسبب في صعوبة في التنفس أو دوخة أو تورم الوجه، الشفتين، الفم، اللسان أو الحَلْق عادة ما تكون مصحوبة بطفح جلدي وحكة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; أزيز بالصدر وشعور بضيق في الصدر (علامات تنم عن الربو). تيبُّس الرقبة (علامات تنم عن اِلْتِهاب السّحَايَا).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; نوبات تشنجية.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; ارتفاع ضغط الدَّم.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تغير لون الجلد إلى اللون الأحمر أو الأرجواني (علامات مُحتملة لالتهاب الأوعية&nbsp; الدَّموية).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مصحوب ببثور، ظهور بثور بالشفتين، العينين والفم، التهاب الجلد مع تساقطه أو تقشُّره.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; اصفرار الجلد أو العينين (علامات تنم عن التهاب الكبد).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; وجود دم بالبول، ازدياد كمية البروتين بالبول، انخفاض شديد في نتاج البول (علامات تنم عن اضطرابات الكُلى).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; التهاب البنكرياس، مما يُسبب ألمًا شديدًا في البطن والظهر صداع مفاجئ وشديد، غثيان، دوخة، تنميل، العجز عن الكلام أو مواجهة صعوبة فيه، شلل (علامات تنم عن سكتة دماغية).</p><p dir="RTL">&nbsp;</p><p dir="RTL">تكون الآثار الجانبية الخطيرة أعلاه نادرة&nbsp; (قد تُؤثر على مايصل إلى شخص واحد من كل 1,000 شخص) أو نادرة جدًّا(قد تُؤثر على ما يصل الى شخص واحد من كل 10000 شخص).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; قد تحدث مشاكل خطيرة بالقلب مثل ألم في الصدر وضيق النفس (علامات تنم عن احتشاء عضلة القلب أو فشل القلب) معدل تكرارها غير شائع (قد تؤثر على ما يصل إلى شخص واحد من بين كل 100 شخص).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; يسمى ألم في الصدر، والذي قد يكون علامة على حدوث تفاعل حساسية ربما يكون خطيرًا بمتلازمة كونيز (معدل التكرار <strong>غير معروف</strong> ،لا يمكن تقديره من واقع البيانات المتاحة).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تقلصات بسيطة وألم في البطن عند الضغط، تبدأ بعد فترة قصيرة من بدء العلاج بعقار ديكلاك ويليهما نزيف من المستقيم أو إسهال دموي عادة ما يحدث في غضون 24 ساعة من بدء آلام البطن (معدل التكرار غير معروف، لا يمكن تقديره من واقع البيانات المتاحة).</p><p dir="RTL"><strong>الآثار الجانبية الأخرى</strong></p><p dir="RTL">الآثار الجانبية الشَّائعة (قد تُؤثر على ما يصل إلى شخص واحد من بين كل 10&nbsp;أشخاص):</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; صداع، دوخة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; غثيان، قيء، إِسْهال، عُسْرُ الهَضْم، ألم في البطن، انتفاخ البطن بالغازات، فقدان الشَّهية.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تغير وظائف الكبد (على سبيل المثال: مستوى الناقلات الأمينية الذي يتم ملاحظته في اختبارات الدَّم).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; الطفح الجلدي.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; دوار</p><p dir="RTL">&nbsp;</p><p dir="RTL">الآثار الجانبية غير الشائعة (قد تُؤثر على ما يصل إلى شخص واحد من بين كل 100 شخص):</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بدقات قلبك (خفقان).</p><p dir="RTL">الآثار الجانبية النادرة (قد تؤثر على ما يصل إلى شخص واحد من بين كل 1000 شخص):</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; نُعاس.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; ألم بالمعدة</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; طفح جلدي مثير للحكة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تورُّم الذراعين، اليدين، الساقين والقدمين (وذمة).</p><p dir="RTL">الآثار الجانبية النادرة جدًّا (قد تؤثر على ما يصل إلى شخص واحد من بين كل 10000 شخص):</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; انخفاض في خلايا الدَّم الحمراء أو البيضاء، مصحوب بأعراض مثل الشحوب، الإرهاق، بول داكن اللون، براز باهت اللون، ازدياد خطر الإصابة بعدوى.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تَوَهان، اكتئاب، قلق، صعوبة النوم، كوابيس، هياج، فقدان الاتصال بالواقع (اضطراب ذهاني). وخز أو تنميل باليدين أو القدمين. ضعف الذاكرة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; ارتجاف.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; مشاكل في التذوق، والرؤية، والسمع (مثل طنين بالأذن).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الرئة الذي يسبب عُسْر التَّنَفُّس وألمًا في الصدر(الالتهاب الرئوي).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; إمساك أو مشاكل أخرى بالأمعاء بما في ذلك التهاب القولون (تتضمن الأعراض إسهالًا مستمرًا) أو تدهور اضطرابات الأمعاء الالتهابية القائمة.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; التهاب الفم، التهاب اللسان، التهاب المَريء.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تقرح المريء (الأنبوب الحامل للطعام من الحَلْق إلى المعدة).</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; طفح القراص، حكة، حساسية جلدية غير معتادة تجاه أشعة الشمس، مما يتسبب في تورم الجلد واحمراره، ظهور بثور بالجلد.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; تساقط الشعر</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;مشاكل شديدة بالكبد.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد ترتبط أدوية مثل عقار ديكلاك بزيادة ضئيلة في خطر الإصابة بالنوبة القلبية (احتشاء عضلة القلب) أو السكتة الدِّماغية.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفظ هذا الدَّواء بعيدًا عن رؤية ومُتناوَل الأطفال.</p><p dir="RTL">لا تستعمل هذا الدَّواء بعد انتهاء تاريخ الصلاحية المدون على الشريط، والعبوة الكرتونية بعد كلمة &quot;EXP&quot;. يُشير تاريخ انتهاء الصَّلاحية إلى اليوم الأخير من ذلك الشهر.</p><p dir="RTL">يُحفَظ في درجة حرارة أقل من 25 درجة مئوية.</p><p dir="RTL">يُحفظ في مكان جاف.</p><p>لا تتخلص من الأدوية عن طريق إلقائها في مياه الصَّرف أو مع المخلفات المنزلية. استشر الصيدلي الخاص بك عن كيفية التَّخلص من الأدوية التي لم تَعُد تستخدمها. ستساعد هذه الإجراءات في الحفاظ على البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي ديكلوفيناك الصوديوم.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; يحتوي القرص الواحد ممتد الإفراز (قرص ثنائي الطبقات) على 75 مجم من ديكلوفيناك الصوديوم:</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; 12.5 مجم من ديكلوفيناك الصوديوم ذي الإفراز الفوري و62.5 مجم من ديكلوفيناك الصوديوم ذي الإفراز البطيء.</p><p dir="RTL">&eth;&nbsp;&nbsp;&nbsp;&nbsp; ويشير الاختصار ID (آي دي) إلى الحرفين الأولين في كلمتي Initial وDepot وتعنِيان التأثير الأولي والمدخر.</p><p dir="RTL">عقار ديكلاك 75 مجم:</p><p>فوسفات هيدروجين الكالسيوم ثنائي الهيدرات، صوديوم نشا كاربوكسي ميثيل (النوع A) (دستور الأدوية الأوروبي)، سليلوز دقيق التَّبلور، هيبروميلوز، لاكتوز أحادي الهيدرات، ستيرات الماغنسيوم (دستور الأدوية الأوروبي)، نشا الذرة، ثاني أكسيد السيليكون الغروي، أكسيد الحديد الثلاثي (E 172).</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">عقار ديكلاك 75 مجم:</p><p dir="RTL">عقار ديكلاك <sup>&reg;</sup> 75 مجم آي دي عبارة عن أقراص مستديرة الشكل وثنائية الطبقات ( لون أبيض، وردي) وسطحها أملس.</p><p dir="RTL">عبوات كرتونية بها 10، 20، 30، 50، 60، 90، 100 أو 100 &times; 1 قرص ممتد الإفراز في شرائط مصنوعة من بولي فينيل الكلوريد/بولي فينيليدين الكلوريد/الألومنيوم أو بولي فينيل الكلوريد/البولي إثيلين/بولي فينيليدين كلوريد/الألومنيوم. قد لا يتم تسويق جميع أحجام العبوة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك حق التَّسويق</strong></p><p dir="RTL">هيكسال إيه جي</p><p dir="RTL">25 شارع إنداستري شتراس، 83607 هولزكيرشن، ألمانيا</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>جهة التَّصنيع</strong></p><p dir="RTL">هيكسال</p><p>أوتو-فون-جويرك آللي 1، 39179 بارلبين، ألمانيا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            07/2020
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Diclac 75 mg prolonged-release tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each prolonged-release tablet contains 75 mg of diclofenac sodium. Excipient with known effect
Each tablet contains 90.8 mg sucrose.

For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Prolonged-release tablet.

Pale pink, triangular, slightly biconvex prolonged-release tablet with bevelled edges. On one side “ID” is debossed, on the other side “CG”.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Symptomatic treatment of:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, osteoarthritis including spondylarthritis</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Periarthritis humeroscapularis (due to the analgetic effect of diclofenac sodium)</p><p>&nbsp;</p><p>Since the formulation of this medicinal product is a prolonged-release formulation, the product is not indicated when a quick onset of efficacy (relief of pain) is required.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>General information</u></p><p>The dose should be individually adjusted. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4).</p><p>&nbsp;</p><p><u>Posology</u></p><p><strong><em>Adults</em></strong></p><p>The recommended initial daily dose is 75-150 mg, administered once or twice daily. In case of mild disorders and for long-term therapy, 75 mg daily is usually sufficient.</p><p>The maximum daily dose is 150 mg.</p><p>&nbsp;</p><p><strong><em>Special populations</em></strong></p><p>&nbsp;</p><p><em>Renal impairment</em></p><p>Diclofenac is contraindicated in patients with severe renal impairment or renal failure (see section 4.3).</p><p>No specific studies have been conducted in patients with impaired renal function; therefore, no specific dose adjustment is recommended. Caution is advised when diclofenac is administered to patients with mild to moderate renal impairment (see section 4.4).</p><p>&nbsp;</p><p><em>Hepatic impairment</em></p><p>Diclofenac is contraindicated in patients with severe hepatic impairment or liver failure (see section 4.3).</p><p>No specific studies have been conducted in patients with impaired liver function; therefore, no specific dose adjustment is recommended. Caution is advised when diclofenac is administered to patients with mild to moderate liver impairment (see section 4.4).</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>Diclac is not recommended for use in children, due to the dose strength.</p><p>&nbsp;</p><p><em>Elderly</em></p><p>Elderly patients should be treated with the lowest effective dose (see also section 4.4).</p><p>&nbsp;</p><p><u>Method of administration</u></p><p>Where the symptoms are most pronounced during the night or in the morning, Diclac should preferably be taken in the evening.</p><p>Diclac should not be divided or chewed.</p><p>The tablets should preferably be swallowed as a whole with liquid during the meal.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                
-	Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
-	Active gastric or intestinal ulcer, bleeding, or perforation (see also section 4.4)
-	History of gastrointestinal bleeding or perforation,  related  to  previous  NSAID  therapy (see sections 4.4 and 4.8)
-	Active or history of recurrent peptic ulcer/hemorrhage (two or more distinct episodes of proven ulceration or bleeding) (see section 4.4 and 4.8)
-	Last trimester of pregnancy (see section 4.6)
-	Severe hepatic impairment and liver failure (see section 4.4)
-	Severe renal impairment and renal failure (see section 4.4)
-	Like other NSAIDs, diclofenac is also contraindicated in patients in whom attacks of asthma, urticaria, or acute rhinitis are precipitated by acetylsalicylic acid or other NSAIDs (see sections 4.4 and 4.8).
-	Active bleedings or bleeding disorders
-	Blood dyscrasias
-	Bone marrow depression
-	Established congestive heart failure (NYHA II-IV)
-	Ischemic heart disease
-	Peripheral arterial disease and/or cerebrovascular disease

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>General</u></p><p>&nbsp;</p><p>Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.2, and gastrointestinal and cardiovascular risks below). Diclofenac sodium should be administered with caution to patients suffering from systemic lupus erythematosus and mixed connective tissue disease.</p><p>The use of diclofenac sodium, as with any medicinal product known to inhibit cyclooxygenase/prostaglandin synthesis, may impair fertility and is not recommended in women attempting to conceive. In women who have difficulty conceiving or are undergoing investigation of infertility, withdrawal of diclofenac sodium should be considered.</p><p>&nbsp;</p><p><u>Gastrointestinal (GI) effects</u></p><p>Gastrointestinal bleeding, ulceration or perforation, which can be fatal, have been reported with all NSAIDs, including diclofenac, and may occur at any time during treatment, with or without warning symptoms or a previous history of serious gastrointestinal events. They generally have more serious consequences in the elderly. If gastrointestinal bleeding or ulceration occurs in patients receiving diclofenac, the medicinal product should be withdrawn.</p><p>&nbsp;</p><p>As with all NSAIDs, including diclofenac, close medical surveillance is imperative and particular caution should be exercised when prescribing diclofenac in patients with symptoms indicative of GI disorders or with a history suggestive of gastric or intestinal ulceration, bleeding or perforation (see section 4.8). The risk of GI bleeding is higher with increasing NSAID doses and in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation and in the elderly.</p><p>&nbsp;</p><p>To reduce the risk of GI toxicity in patients with a history of ulcer, particularly if complicated with haemorrhage or perforation, and in the elderly, the treatment should be initiated and maintained at the lowest effective dose.</p><p>&nbsp;</p><p>Combination therapy with protective agents (e.g. proton pump inhibitors or misoprostol) should be considered for these patients, and also for patients requiring concomitant use of medicinal products containing low-dose acetylsalicylic acid (ASA) or other medicinal products likely to increase gastrointestinal risk (see below and section 4.5).</p><p>&nbsp;</p><p>Patients with a history of GI toxicity, particularly the elderly, should report any unusual abdominal symptoms (especially GI bleeding). Caution is recommended in patients receiving concomitant medications which could increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin-reuptake inhibitors or anti-platelet medicinal products such as acetylsalicylic acid (see section 4.5).</p><p>&nbsp;</p><p>Close medical surveillance and caution should also be exercised in patients with ulcerative colitis or Crohn&rsquo;s disease, as their condition may be exacerbated (see section 4.8).</p><p>&nbsp;</p><p>NSAIDs, including diclofenac, may be associated with increased risk of gastro-intestinal anastomotic leak. Close medical surveillance and caution are recommended when using diclofenac after gastro- intestinal surgery.</p><p>&nbsp;</p><p><u>Pre-existing asthma</u></p><p>In patients with asthma, seasonal allergic rhinitis, swelling of the nasal mucosa (i.e. nasal polyps), chronic obstructive pulmonary diseases or chronic infections of the respiratory tract (especially if linked to allergic rhinitis-like symptoms), reactions on NSAIDs like asthma exacerbations (so-called intolerance to analgesics/analgesics-asthma), Quincke&rsquo;s oedema or urticaria are more frequent than in other patients. Therefore, special precaution is recommended in such patients (readiness for</p><p>&nbsp;</p><p>emergency). This is applicable as well for patients who are allergic to other substances, e.g. with skin reactions, pruritus or urticaria.</p><p>&nbsp;</p><p><u>Skin reactions</u></p><p>Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs, including diclofenac (see section 4.8). Patients appear to be at highest risk of these reactions early in the course of therapy, the onset of the reaction occurring in the majority of cases within the first month of treatment. Diclofenac should be discontinued at the first appearance of skin rash, mucosal lesions or any other sign of hypersensitivity.</p><p>&nbsp;</p><p>As with other NSAIDs, allergic reactions, including anaphylactic/anaphylactoid reactions, can also occur in rare cases with diclofenac without earlier exposure to the active substance. Hypersensitivity reactions can also progress to Kounis syndrome, a serious allergic reaction that can result in myocardial infarction. Presenting symptoms of such reactions can include chest pain occurring in association with an allergic reaction to diclofenac.</p><p>&nbsp;</p><p><u>Hepatic effects</u></p><p>Close medical surveillance is required when prescribing diclofenac to patients with impaired hepatic function, as their condition may be exacerbated.</p><p>As with other NSAIDs, including diclofenac, values of one or more liver enzymes may increase. During prolonged treatment with diclofenac, regular monitoring of hepatic function is indicated as a precautionary measure. If abnormal liver function tests persist or worsen, if clinical signs or symptoms consistent with liver disease develop, or if other manifestations occur (e.g. eosinophilia, rash), diclofenac should be discontinued. Hepatitis may occur with use of diclofenac without prodromal symptoms.</p><p>Caution is called for when using diclofenac in patients with hepatic porphyria, since it may trigger an attack.</p><p>&nbsp;</p><p><u>Renal effects</u></p><p>As fluid retention and oedema have been reported in association with NSAID therapy, including diclofenac, particular caution is called for in patients with impaired cardiac or renal function, history of hypertension, the elderly, patients receiving concomitant treatment with diuretics or medicinal products that can significantly impact renal function, and in those patients with substantial extracellular volume depletion from any cause, e.g. before or after major surgery. Monitoring of renal function is recommended as a precautionary measure when using diclofenac in such cases.</p><p>Discontinuation of therapy is usually followed by recovery to the pre-treatment state.</p><p>When NSAIDs including diclofenac are combined with diuretics, ACE inhibitors or angiotensin II receptor antagonists, the risk of worsening of renal function, including possible acute renal failure may be increased in some patients, especially when renal function is compromised (see section 4.5).</p><p>&nbsp;</p><p><u>Cardiovascular and cerebrovascular effects</u></p><p>Appropriate monitoring and advice are required for patients with a history of hypertension and/or congestive heart failure (NYHA I) as fluid retention and oedema have been reported in association with NSAID therapy.</p><p>&nbsp;</p><p>Clinical trial and epidemiological data consistently point towards an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150 mg daily) and in long term treatment.</p><p>&nbsp;</p><p>Patients with congestive heart failure (NYHA I) or significant risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) should only be treated with diclofenac after careful consideration (see section 4.3 for which cardiovascular patients diclofenac should not be prescribed).</p><p>&nbsp;</p><p>As the cardiovascular risks of diclofenac may increase with dose and duration of exposure, the shortest duration possible and the lowest effective daily dose should be used. The patient&#39;s need for symptomatic relief and response to therapy should be re-evaluated periodically.</p><p>&nbsp;</p><p>Patients should be alert for signals and symptoms of severe arterial thrombotic events (e.g. chest pain, shortness of breath, weakness, delayed speaking) that may occur without warning signs. Patients should be instructed to consult a doctor immediately in these cases.</p><p>&nbsp;</p><p><u>Haematological effects</u></p><p>During prolonged treatment with diclofenac, as with other NSAIDs, monitoring of the blood count is recommended.</p><p>&nbsp;</p><p>Like other NSAIDs, diclofenac may temporarily inhibit platelet aggregation and prolong bleeding time. Patients with defects of haemostasis should be carefully monitored.</p><p>&nbsp;</p><p><u>Elderly</u></p><p>Caution is indicated in the elderly on basic medical grounds. In particular, it is recommended that the lowest effective dose be used in frail elderly patients or those with a low body weight.</p><p>Elderly patients are more likely to suffer from impaired renal, cardiovascular or hepatic function, so careful supervision is required.</p><p>The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and perforation which may be fatal (see section 4.2).</p><p>&nbsp;</p><p><u>Interaction with NSAIDs</u></p><p>The concomitant use of diclofenac with systemic NSAIDs including cyclooxygenase-2 selective inhibitors should be avoided due to the absence of any evidence demonstrating synergistic benefits and the potential for additive undesirable effects (see section 4.5).</p><p>&nbsp;</p><p><u>Masking signs of infection</u></p><p>Like other NSAIDs, diclofenac may mask the signs and symptoms of infection due to its pharmacodynamic properties.</p><p>Exceptionally, varicella can be at the origin of serious cutaneous and soft tissues infectious complications. To date, the contributing role of NSAIDs in the worsening of these infections cannot be ruled out. Thus, it is advisable to avoid use of Diclac in case of varicella infection.</p><p>&nbsp;</p><p>Diclac contains sodium and sucrose</p><p>This medicinal product contains sucrose. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.</p><p>This medicine contains less than 1 mmol (23 mg) sodium per prolonged release tablet, that is to say essentially &lsquo;sodium-free&rsquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Observed interactions to be considered</u></p><p>&nbsp;</p><p><em>Potent CYP2C9 inhibitors</em></p><p>Caution is recommended when co-prescribing diclofenac with CYP2C9 inhibitors (such as fluconazole, amiodarone, voriconazole and sulfinpyrazone), which could result in a significant increase in peak plasma concentrations and exposure to diclofenac due to inhibition of diclofenac metabolism. Co-administration of voriconazole resulted in 78% and 114% increase in diclofenac AUC and Cmax, respectively.</p><p>&nbsp;</p><p><em>Lithium</em></p><p>If used concomitantly, diclofenac may raise plasma concentrations of lithium. Monitoring of the serum lithium level is recommended.</p><p>&nbsp;</p><p><em>Digoxin</em></p><p>If used concomitantly, diclofenac may raise plasma concentrations of digoxin. Monitoring of the serum digoxin level is recommended.</p><p>&nbsp;</p><p><em>Diuretics and antihypertensive medicinal products</em></p><p>NSAIDs including diclofenac may reduce the effect of diuretics and antihypertensive medicinal products. Therefore, the combination should be administered with caution and patients, especially the elderly, should have their blood pressure periodically monitored. When NSAIDs including diclofenac are combined with diuretics, ACE inhibitors or angiotensin II receptor antagonists, the risk of worsening of renal function, including possible acute renal failure (which is usually reversible) may be increased in some patients, especially when renal function is compromised (e.g. dehydrated or elderly patients). Therefore, the combination should be administered with caution, especially in the elderly. Patients should be adequately hydrated and consideration should be given to monitoring of renal function after initiation of concomitant therapy and periodically thereafter, particularly for diuretics and ACE inhibitors due to the increased risk of nephrotoxicity (see section 4.4).</p><p>&nbsp;</p><p><em>Ciclosporin</em></p><p>Diclofenac, like other NSAIDs, may increase the nephrotoxicity of ciclosporin due to the effect on renal prostaglandins. In addition, it has been reported that ciclosporin can enhance the plasma concentrations of diclofenac by about 100%. Therefore, diclofenac should be given at doses lower than those that would be used in patients not receiving ciclosporin.</p><p>&nbsp;</p><p><em>Medicinal products known to cause hyperkalaemia</em></p><p>Concomitant treatment with potassium-sparing diuretics, ciclosporin, tacrolimus or trimethoprim may be associated with increased serum potassium levels, which should therefore be monitored frequently (see section 4.4).</p><p>&nbsp;</p><p><em>Quinolone antibacterials</em></p><p>There have been isolated reports of convulsions which may have been due to concomitant use of quinolones and NSAIDs.</p><p>&nbsp;</p><p>B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <u>Anticipated interactions to be considered</u></p><p><em>Other NSAIDs and corticosteroids</em></p><p>Concomitant administration of diclofenac together with other systemic NSAIDs or corticosteroids may increase the frequency of gastrointestinal undesirable effects (see section 4.4). Concomitant administration of acetylsalicylic acid decreases the plasma concentration of diclofenac, without compromising clinical efficacy.</p><p>&nbsp;</p><p><em>Anticoagulants and anti-platelet medicinal products</em></p><p>&nbsp;</p><p>Caution is recommended since concomitant administration could increase the risk of bleeding (see section 4.4). Although clinical investigations do not appear to indicate that diclofenac affects the action of anticoagulants, there are reports of an increased risk of haemorrhage in patients receiving diclofenac and anticoagulants concomitantly. Close monitoring of such patients is therefore recommended.</p><p>&nbsp;</p><p><em>Selective serotonin reuptake inhibitors (SSRIs)</em></p><p>Concomitant administration of systemic NSAIDs, including diclofenac, and SSRIs may increase the risk of gastrointestinal bleeding (see section 4.4).</p><p>&nbsp;</p><p><em>Antidiabetics</em></p><p>Clinical studies have shown that diclofenac can be given together with oral antidiabetics without influencing their clinical effect. However, there have been isolated reports of both hypoglycaemic and hyperglycaemic effects necessitating changes in the dose of the antidiabetics during treatment with diclofenac. For this reason, monitoring of the blood glucose level is recommended as a precautionary measure during concomitant therapy.</p><p>&nbsp;</p><p><em>Phenytoin</em></p><p>When using phenytoin concomitantly with diclofenac, monitoring of phenytoin plasma concentrations is recommended due to an expected increase in exposure to phenytoin.</p><p>&nbsp;</p><p><em>Methotrexate</em></p><p>Diclofenac can inhibit the tubular renal clearance of methotrexate hereby increasing methotrexate levels. Caution is recommended when NSAIDs, including diclofenac, are administered less than 24 hours before or after treatment with methotrexate, since blood concentrations of methotrexate may rise and the toxicity of this substance be increased.</p><p>&nbsp;</p><p><em>Colestipole and colestyramine</em></p><p>Colestipole/colestyramine may delay or reduce the absorption of diclofenac. It is therefore recommended that diclofenac should be taken at least 1 hour before, or 4 to 6 hours after, the administration of colestipole/colestyramine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Inhibition of prostaglandin synthesis may adversely affect the pregnancy and/or the embryo/foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and of cardiac malformation and gastroschisis after use of a prostaglandin synthesis inhibitor in early pregnancy. The absolute risk for cardiovascular malformation was increased from less than 1%, up to approximately 1.5%.</p><p>The risk is believed to increase with dose and duration of therapy. In animals, administration of a prostaglandin synthesis inhibitor has been shown to result in increased pre- and post-implantation loss and embryo-foetal lethality.</p><p>In addition, increased incidences of various malformations, including cardiovascular, have been reported in animals given a prostaglandin synthesis inhibitors during the organogenetic period.</p><p>&nbsp;</p><p>During the first and second trimester of pregnancy, diclofenac should not be given unless clearly necessary. If diclofenac is used by a woman attempting to conceive, or during the first and second trimester of pregnancy, the dose should be kept as low and duration of treatment as short as possible.</p><p>&nbsp;</p><p>During the third trimester of pregnancy, all prostaglandin synthesis inhibitors may expose</p><p>&nbsp;</p><p>the foetus to:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension);</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; renal dysfunction, which may progress to renal failure with oligo-hydroamniosis;</p><p>&nbsp;</p><p>the mother and the neonate, at the end of pregnancy, to:</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; possible prolongation of bleeding time, an anti-aggregating effect which may occur even at very low doses;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; inhibition of uterine contractions resulting in delayed or prolonged labour.</p><p>&nbsp;</p><p>Consequently, diclofenac is contraindicated during the third trimester of pregnancy (see sections 4.3 and 5.3).</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>Like other NSAIDs, diclofenac passes into breast milk in small amounts. Therefore, diclofenac should not be administered during breast-feeding in order to avoid undesirable effects in the infant.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>As with other NSAIDs, the use of diclofenac may impair female fertility and is not recommended in women attempting to conceive. In women who have difficulties conceiving or who are undergoing investigation of infertility, withdrawal of diclofenac should be considered.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product has no or negligible influence on the ability to drive and use machines. However, patients experiencing visual disturbances, dizziness, vertigo, somnolence or other central nervous system disturbances while taking diclofenac, should refrain from driving or using machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse drug reactions from clinical trials and/or spontaneous or literature cases (Table below) are listed by MedDRA system organ class. Within each system organ class, the adverse drug reactions are ranked by frequency, with the most frequent reactions first. Within each frequency grouping, adverse drug reactions are presented in order of decreasing seriousness. In addition, the corresponding frequency category for each adverse drug reaction is based on the following convention (CIOMS III): very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &lt;1/100); rare (&ge;1/10,000 to &lt;1/1,000); very rare (&lt;1/10,000); not known (cannot be estimated from the available data).</p><p>&nbsp;</p><p>The following undesirable effects include those reported with diclofenac gastro-resistant tablets and/or other pharmaceutical forms of diclofenac, with either short-term or long-term use.</p><p>&nbsp;</p><p>Table: Adverse drug reactions</p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td colspan="3" style="vertical-align:top"><p>Blood and lymphatic system disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Thrombocytopenia, leukopenia, anaemia (including haemolytic and aplastic anaemia), agranulocytosis</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Immune system disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hypersensitivity, anaphylactic and anaphylactoid reactions (including hypotension and shock)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Angioedema (including face oedema)</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Psychiatric disorders</p></td></tr></tbody></table><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Disorientation, depression, insomnia, nightmare, irritability,</p><p>psychotic disorder, anxiety</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Nervous system disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Headache, dizziness</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Somnolence</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Paraesthesia, memory impairment, convulsion, tremor,</p><p>meningitis aseptic, dysgeusia, cerebrovascular accident</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Eye disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Decreased vision, vision blurred, diplopia</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Ear and labyrinth disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Common :</p></td><td style="vertical-align:top"><p>Vertigo</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Tinnitus, hearing impaired</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Cardiac disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Uncommon*:</p></td><td style="vertical-align:top"><p>Myocardial infarction, cardiac failure, palpitations, chest pain</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Frequency not known</p></td><td style="vertical-align:top"><p>Kounis syndrome</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Vascular disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Hypertension, vasculitis</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Respiratory, thoracic and mediastinal disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Asthma (including dyspnoea)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Pneumonitis</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Gastrointestinal disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Nausea, vomiting, diarrhoea, dyspepsia, abdominal pain,</p><p>flatulence, decreased appetite</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Gastritis, gastrointestinal haemorrhage, haematemesis, diarrhoea</p><p>haemorrhagic, melaena, gastrointestinal ulcer (with or without bleeding or perforation)</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Colitis (including haemorrhagic colitis and exacerbation of</p><p>ulcerative colitis or Crohn&#39;s disease), constipation, stomatitis, glossitis, oesophageal disorder, intestinal diaphragm disease, pancreatitis</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Frequency not known</p></td><td style="vertical-align:top"><p>Ischaemic colitis</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Hepatobiliary disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Transaminases increased</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hepatitis, jaundice, liver disorder</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Hepatitis fulminant, hepatic necrosis, hepatic failure</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Skin and subcutaneous tissue disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Common:</p></td><td style="vertical-align:top"><p>Rash</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Urticaria</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Dermatitis bullous, eczema, erythema, erythema multiforme,</p><p>Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell&#39;s syndrome), dermatitis exfoliative, alopecia, photosensitivity reaction, purpura, Henoch-Sch&ouml;nlein purpura, pruritus</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>Renal and urinary disorders</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Very rare:</p></td><td style="vertical-align:top"><p>Renal failure acute, haematuria, proteinuria, nephrotic</p><p>syndrome, tubulo-interstitial nephritis, renal papillary necrosis</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p>General disorders and administration site conditions</p></td></tr><tr><td style="vertical-align:top"><p>&nbsp;</p></td><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Oedema</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>* The frequency reflects data from the long-term treatment with high-dose diclofenac (150 mg/day).</p><p><br />Clinical trial and epidemiological data consistently point towards an increased risk of arterial thrombotic events (for example myocardial infarction or stroke) associated with the use of diclofenac, particularly at high dose (150 mg daily) and in long term treatment (see sections 4.3 and 4.4).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Symptoms</u></p><p>There is no typical clinical picture resulting from diclofenac overdose. Overdose can cause symptoms such as vomiting, gastrointestinal haemorrhage, diarrhoea, dizziness, tinnitus or convulsions. In the event of significant poisoning, acute renal failure and liver damage are possible.</p><p>&nbsp;</p><p><u>Therapeutic measures</u></p><p>Management of acute poisoning with NSAIDs, including diclofenac, essentially consists of supportive measures and symptomatic treatment. Supportive measures and symptomatic treatment should be given for complications such as hypotension, renal failure, convulsions, gastrointestinal disorder, and respiratory depression.</p><p>&nbsp;</p><p>Special measures such as forced diuresis, dialysis or haemoperfusion are probably of no help in eliminating NSAIDs, including diclofenac, due to the high protein binding and extensive metabolism.</p><p>&nbsp;</p><p>Activated charcoal may be considered after ingestion of a potentially toxic overdose, and gastric decontamination (e.g. vomiting, gastric lavage) after ingestion of a potentially life-threatening overdose.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Antiinflammatory and antirheumatic products, non-steroids, ATC code: M01AB05</p><p>&nbsp;</p><p><u>Mechanism of action</u></p><p>Diclac contains the prostaglandin synthetase inhibitor diclofenac sodium. This is a phenylacetic acid derivative with anti-inflammatory, analgesic and antipyretic properties.</p><p>Inhibition of prostaglandin biosynthesis (demonstrated in experiments), is considered fundamental to its mechanism of action. Prostaglandins play a major role in causing of inflammation, pain and fever.</p><p>&nbsp;</p><p><u>Pharmacodynamic effects</u></p><p>In rheumatic diseases the anti-inflammatory and analgesic properties of diclofenac sodium elicit a clinical response, characterised by marked relief from signs and symptoms such as pain at rest, pain on movement, morning stiffness and swelling of the joints, as well as by an improvement in function.</p><p>&nbsp;</p><p>The active substance is released controlled by Diclac . This prolongs the effect of the tablets. Diclofenac sodium prolonged-release tablets are particularly suitable for patients in whom a daily dose of 75 or 100</p><p>&nbsp;</p><p>mg is needed. These patients only have to take Diclac once daily, simplifying the treatment. It is also possible to administer a dose of 150 mg by means of taking a diclofenac sodium 75 mg prolonged- release tablet twice daily.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Absorption:</em></p><p>It can be deducted from the renal elimination of diclofenac and its hydroxylated metabolites that proportionally the same amount of diclofenac is released and absorbed from diclofenac sodium prolonged-release tablets as from the gastro-resistant tablets.</p><p>Probably as a result of a rate depending first pass effect the systemic availability of diclofenac from diclofenac prolonged-release tablets is about 82% of an equal dose administered as gastro-resistant tablets.</p><p>&nbsp;</p><p>As a result of the slower release of the active ingredient the peak plasma concentrations are lower than those obtained via conventional dosage forms. Mean peak plasma concentrations of</p><p>0.5 microgram/ml respectively 0.4 microgram/ml (1.6 respectively 1.25 micromol/l) are reached on average 4 hours after ingestion of one prolonged-release tablet of 100 and 75 mg diclofenac sodium respectively.</p><p><!--[if gte vml 1]><v:line
 id="_x0000_s1026" style='position:absolute;left:0;text-align:left;z-index:-19888;
 mso-position-horizontal-relative:page' from="72.85pt,26.15pt" to="72.85pt,39.25pt"
 strokecolor="silver" strokeweight="3.84pt">
 <w:wrap anchorx="page"/>
</v:line><![endif]--><img width="6" height="23" src="file:///C:/Users/aldakmo1/AppData/Local/Temp/2/msohtmlclip1/01/clip_image001.gif" />On the other hand a concentration of 13 nanogram/ml (40 nanomol/l) is still found 24 hours (respectively 16 hours) after ingestion of diclofenac sodium 100 mg prolonged-release tablets respectively Diclac , 75 mg.</p><p>&nbsp;</p><p>The passage of a gastro-resistant tablet through the stomach is slower when ingested with or after a meal than when it is taken before a meal. The amount of diclofenac absorbed remains the same. For this reason diclofenac sodium gastro-resistant tablets should preferably be taken before meals.</p><p>&nbsp;</p><p>This is contrary to diclofenac sodium prolonged-release tablets, where a quick action is not necessary. A diclofenac sodium prolonged-release tablet contains a higher dose of diclofenac. To reduce the risk of gastro-intestinal side-effects to a minimum diclofenac sodium prolonged-release tablets should preferably be taken during the meal.</p><p>Food has no clinical relevant influence on the absorption and systemic availability of diclofenac sodium prolonged-release tablets.</p><p>&nbsp;</p><p>Since about half of the active substance is metabolised during its first passage through the liver (first pass effect), the bioavailability after oral ingestion is about 50% of that after parenteral administration of an equal dose.</p><p>&nbsp;</p><p>Pharmacokinetic behaviour does not change after repeated administration. No accumulation occurs provided the recommended dosage intervals are observed.</p><p>&nbsp;</p><p>Trough concentrations are around 22 ng/ml or 25 ng/ml (70 nmol/l or 80 nmol/l) during treatment with a diclofenac sodium 100 mg prolonged-release tablet once daily, respectively Diclac , 75 mg,twice daily.</p><p>&nbsp;</p><p><u>Distribution</u></p><p>Diclofenac is bound to serum proteins at a rate of 99.7%, mainly to albumin (99.4%). The apparent volume of distribution calculated is 0.12-0.17 l/kg.</p><p>&nbsp;</p><p>Diclofenac enters the synovial fluid, where maximum concentrations are measured 2-4 hours after the peak plasma values have been attained. The apparent half-life for elimination from the synovial fluid is 3-6 hours. Two hours after reaching peak plasma values, concentrations of the active substance are already higher in the synovial fluid than they are in the plasma and remain higher for up to 12 hours.</p><p>&nbsp;</p><p>Diclofenac and its metabolites cross the placenta and traces of diclofenac have been found in the milk of lactating women (100 ng/ml). The estimated amount ingested by an infant consuming breast milk is equivalent to a 0.03 mg/kg/day dose.</p><p>&nbsp;</p><p><u>Biotransformation</u></p><p>The biotransformation of diclofenac takes place partly by glucuronidation of the intact molecule, but mainly by single and multiple hydroxylation and methoxylation, resulting in several phenolic metabolites (3&rsquo;-hydroxy-, 4&rsquo;-hydroxy, 5&rsquo;-hydroxy, 4&rsquo;,5&rsquo;-dihydroxy-, 3&rsquo;-hydroxy-4&rsquo;-methoxy- diclofenac), most of which are converted to glucuronide conjugates. Two of these phenolic metabolites are biologically active, but to a smaller extent than diclofenac.</p><p>&nbsp;</p><p><u>Elimination</u></p><p>The total systemic clearance of diclofenac in plasma is 263 &plusmn; 56 ml/min (mean value &plusmn; SD). The terminal half-life in plasma is 1-2 hours.</p><p>Four of the metabolites, including the two active ones, also have short plasma half-lives of 1-3 hours. One metabolite, 3&rsquo;-hydroxy-4&rsquo;-methoxy-diclofenac has a much longer plasma half-life. However, this metabolite is virtually inactive.</p><p>&nbsp;</p><p>About 60% of the administered dose is excreted in the urine in the form of metabolites from one of these processes; less than 1% is excreted as unchanged substance. The remainder of the dose is eliminated as metabolites through the bile in the faeces.</p><p>&nbsp;</p><p><u>Linearity/non-linearity</u></p><p>The amount absorbed is linearly related to the size of the dose.</p><p>&nbsp;</p><p><u>Special populations</u></p><p>No relevant age-dependent differences in the absorption, metabolism or excretion of the active substance have been observed.</p><p>&nbsp;</p><p>In patients suffering from renal impairment, no accumulation of the unchanged active substance can be inferred from the single-dose kinetics when applying the usual dose schedule. At a creatinine clearance of below 10 ml/min, the theoretical steady-state plasma levels of hydroxy-metabolites are about 4 times higher than in normal subjects.</p><p>However, the metabolites are ultimately cleared through the bile.</p><p>&nbsp;</p><p>In patients with chronic hepatitis or non-decompensated cirrhosis, the kinetics and metabolism of diclofenac are the same as in patients without liver disease.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data reveal no special hazard for humans in the intended therapeutic doses. These data are based on conventional studies of acute and repeated dose toxicity, genotoxicity, mutagenicity and carcinogenicity.</p><p>&nbsp;</p><p>In studies on reproduction toxicity the following results were found:</p><p>&nbsp;</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Administration of NSAIDs (including diclofenac) inhibited ovulation in the rabbit and implantation and placentation in the rat, and led to premature closure of the ductus arteriosus in the pregnant rat. Maternally toxic doses of diclofenac were associated with dystocia, prolonged gestation, decreased foetal survival, and intrauterine growth retardation in rats.</p><p>-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Diclofenac had no influence on the fertility of parent animals in rats, showed no evidence of a teratogenic potential in standard embryo-foetal developmental studies in mice, rats or rabbits, and did not affect the prenatal, perinatal and postnatal development of the offspring with the exception of foetal effects at maternally toxic doses.</p><p>&nbsp;</p><p>The effects of diclofenac on reproduction parameters and delivery as well as constriction of the ductus arteriosus <em>in utero </em>are pharmacologic consequences of this class of prostaglandin synthesis inhibitors (see sections 4.3 and 4.6).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>calcium hydrogen phosphate dihydrate, carboxymethyl starch sodium (type A) (Ph.Eur.), microcrystalline cellulose, hypromellose, lactose monohydrate, magnesium stearate (Ph.Eur.), maize starch, colloidal silicon dioxide, ferric(ll) oxide (E 172).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store below 25&deg;C. Store in a dry place</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The prolonged-release tablets are packed in PVC/PVDC/Aluminium or PVC/PE/PVDC/Aluminium blisters and inserted in a carton.</p><p>One prolonged-release tablet (two-layer tablet) contains 75 mg diclofenac sodium:</p><p>12.5 mg diclofenac sodium, immediate release and 62.5 mg diclofenac sodium, slow release. The abbreviation ID stands for Initial and Depot effect.</p><p>Diclac &reg; 75 mg ID are round bilayer tablets (white, pink) with plain surface. Pack sizes:</p><p>&nbsp;</p><p>10, 20, 30, 50, 60, 90, 100 and 100 x 1 prolonged-release tablets Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                HEXAL AG, Holzkirchen, Germany
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                07/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>